Ignite Creation Date:
2024-05-06 @ 3:06 AM
Last Modification Date:
2024-10-26 @ 11:28 AM
Study NCT ID:
NCT02201992
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2014-07-21
Brief Title:
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations An ALCHEMIST Treatment Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Organization:
Eastern Cooperative Oncology Group
Organization Data
Organization:
Eastern Cooperative Oncology Group
Class:
NETWORK
Study ID:
E4512
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
ECOG-ACRIN Cancer Research Group
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| National Cancer Institute NCI | NIH |